Monday, September 27, 2004
Prescription trips
In Wired News, Kristen Philipkoski reports on FDA- and DEA-approved clinical trials of psychedelic drugs. For example, psylocibin is now being tested to treat obsessive-compulsive disorder and cluster headaches. Meanwhile, a proposal for studying MDMA's effectiveness as an anti-anxiety treatment for terminal cancer patients is undergoing review at Harvard. Paging Dr. Leary! Link
posted by David Pescovitz at 05:40:32 AM permalink | Other blogs' comments
